Dr Angel E Torano, MD | |
2002 Medical Pkwy, Suite 235, Annapolis, MD 21401-3046 | |
(410) 266-2770 | |
(410) 841-6251 |
Full Name | Dr Angel E Torano |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 37 Years |
Location | 2002 Medical Pkwy, Annapolis, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174525935 | NPI | - | NPPES |
054551100 | Medicaid | MD | |
8317071 | Other | MD | AETNA PPO |
10690010 | Other | MD | BCBS |
300059958 | Other | MD | TRAVELERS RR MEDICARE |
2622593 | Other | MD | AETNA HMO/POS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | D0037374 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Anne Arundel Medical Center | Annapolis, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Brown, Croft, Frazier, Pa | 9537101746 | 24 |
News Archive
Today, the United States Surgeon General issued a call to action to address major public health challenges such as heart disease and diabetes. Step It Up! The Surgeon General's Call to Action to Promote Walking and Walkable Communities articulates the health benefits of walking while addressing the fact that many communities unacceptably lack safe and convenient places for individuals to walk or wheelchair roll.
Experts are still grappling with facts and fiction regarding brain damage caused by cell phone use. Dr. Nora Volkow, who is lead author of a new study published in the Feb. 23 issue of the Journal of the American Medical Association said, "We don't know whether this is detrimental or whether it could have some potential beneficial effects.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treatments and cures to disease and injury at The New York Stem Cell Foundation's Seventh Annual Translational Stem Cell Research Conference, held at The Rockefeller University in Manhattan on October 10-11.
› Verified 7 days ago
Entity Name | Brown, Croft, Frazier, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902807324 PECOS PAC ID: 9537101746 Enrollment ID: O20050527000410 |
News Archive
Today, the United States Surgeon General issued a call to action to address major public health challenges such as heart disease and diabetes. Step It Up! The Surgeon General's Call to Action to Promote Walking and Walkable Communities articulates the health benefits of walking while addressing the fact that many communities unacceptably lack safe and convenient places for individuals to walk or wheelchair roll.
Experts are still grappling with facts and fiction regarding brain damage caused by cell phone use. Dr. Nora Volkow, who is lead author of a new study published in the Feb. 23 issue of the Journal of the American Medical Association said, "We don't know whether this is detrimental or whether it could have some potential beneficial effects.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treatments and cures to disease and injury at The New York Stem Cell Foundation's Seventh Annual Translational Stem Cell Research Conference, held at The Rockefeller University in Manhattan on October 10-11.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Angel E Torano, MD 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401-3046 Ph: (410) 266-2770 | Dr Angel E Torano, MD 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401-3046 Ph: (410) 266-2770 |
News Archive
Today, the United States Surgeon General issued a call to action to address major public health challenges such as heart disease and diabetes. Step It Up! The Surgeon General's Call to Action to Promote Walking and Walkable Communities articulates the health benefits of walking while addressing the fact that many communities unacceptably lack safe and convenient places for individuals to walk or wheelchair roll.
Experts are still grappling with facts and fiction regarding brain damage caused by cell phone use. Dr. Nora Volkow, who is lead author of a new study published in the Feb. 23 issue of the Journal of the American Medical Association said, "We don't know whether this is detrimental or whether it could have some potential beneficial effects.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treatments and cures to disease and injury at The New York Stem Cell Foundation's Seventh Annual Translational Stem Cell Research Conference, held at The Rockefeller University in Manhattan on October 10-11.
› Verified 7 days ago
Luqman K Dad, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Quang Nguyen, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark S Radowich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Thomas B. Lank, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 122 Defense Hwy, Chesapeake Medical Imaging, Annapolis, MD 21401 Phone: 410-571-0350 Fax: 410-571-9348 | |
Dr. Frank J Groshek, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy Ste 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark Cameron Davis, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 845 Coachway, Annapolis, MD 21401 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Kerry J. Thompson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 |